LACQUANITI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 4.484
EU - Europa 2.581
AS - Asia 2.373
SA - Sud America 839
AF - Africa 78
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.365
Nazione #
US - Stati Uniti d'America 4.411
SG - Singapore 958
CN - Cina 762
BR - Brasile 743
IE - Irlanda 687
SE - Svezia 643
HK - Hong Kong 274
DE - Germania 266
IT - Italia 236
FI - Finlandia 157
GB - Regno Unito 127
IN - India 98
FR - Francia 97
RU - Federazione Russa 96
VN - Vietnam 90
UA - Ucraina 80
PL - Polonia 67
AR - Argentina 37
CA - Canada 35
BE - Belgio 29
TR - Turchia 29
MX - Messico 27
ZA - Sudafrica 23
BD - Bangladesh 21
CZ - Repubblica Ceca 19
EC - Ecuador 18
IQ - Iraq 18
ES - Italia 17
MA - Marocco 16
UZ - Uzbekistan 15
ID - Indonesia 14
JP - Giappone 14
NL - Olanda 14
AE - Emirati Arabi Uniti 12
AT - Austria 12
CO - Colombia 12
KE - Kenya 8
AZ - Azerbaigian 7
VE - Venezuela 7
CI - Costa d'Avorio 6
EG - Egitto 6
PE - Perù 6
PK - Pakistan 6
UY - Uruguay 6
AU - Australia 5
IL - Israele 5
KG - Kirghizistan 5
PS - Palestinian Territory 5
TN - Tunisia 5
AM - Armenia 4
BG - Bulgaria 4
CH - Svizzera 4
JO - Giordania 4
SN - Senegal 4
BH - Bahrain 3
BO - Bolivia 3
DZ - Algeria 3
JM - Giamaica 3
LK - Sri Lanka 3
LT - Lituania 3
LV - Lettonia 3
NI - Nicaragua 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AO - Angola 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CL - Cile 2
DK - Danimarca 2
EU - Europa 2
GA - Gabon 2
GY - Guiana 2
HN - Honduras 2
IR - Iran 2
IS - Islanda 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RO - Romania 2
RS - Serbia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
ML - Mali 1
MY - Malesia 1
NG - Nigeria 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 10.361
Città #
Dublin 687
Ashburn 623
Chandler 587
Dallas 580
Singapore 471
Beijing 329
Nyköping 326
Hong Kong 274
Jacksonville 225
New York 210
Dearborn 128
The Dalles 124
Ann Arbor 119
Los Angeles 115
Munich 104
Princeton 103
Medford 101
Cambridge 97
Messina 96
Des Moines 72
Warsaw 56
São Paulo 55
Boardman 54
Bremen 46
Buffalo 45
Houston 45
Jinan 44
San Mateo 44
Shenyang 38
Turku 36
Pune 35
Lancaster 34
Ho Chi Minh City 33
Hyderabad 32
Redondo Beach 31
Wilmington 28
Brussels 27
Moscow 25
Rio de Janeiro 25
Tianjin 25
Woodbridge 25
Hanoi 24
Hebei 24
Frankfurt am Main 23
Lentini 22
Nanjing 22
Curitiba 21
Helsinki 21
Seattle 21
Belo Horizonte 20
Brasília 20
Brooklyn 20
Düsseldorf 20
Poplar 17
Denver 15
Ningbo 15
Stockholm 15
Hangzhou 14
Zhengzhou 14
Ankara 13
Nanchang 13
San Francisco 13
Tashkent 13
Tokyo 13
Chennai 12
Orem 12
Phoenix 12
Porto Alegre 12
Haikou 11
Jiaxing 11
Montreal 11
Santa Clara 11
Boston 10
Johannesburg 10
Milan 10
Nuremberg 10
Shanghai 10
Amsterdam 9
Atlanta 9
Brno 9
Campinas 9
Charlotte 9
Guangzhou 9
Jakarta 9
London 9
San Jose 9
Vienna 9
Wroclaw 9
Chicago 8
Falls Church 8
Lauterbourg 8
Norwalk 8
Ribeirão Preto 8
Rome 8
Salvador 8
Baku 7
Bexley 7
Caxias do Sul 7
Columbus 7
Guarulhos 7
Totale 6.899
Nome #
3 Tesla-Diffusion Tensor Imaging in Autosomal Dominant Polycystic Kidney Disease: The Nephrologist's Point of View 208
Acute pulmonary exacerbation and lung function decline in patients with cystic fibrosis: high-mobility group box 1 (HMGB1) between inflammation and infection. 186
Metformin-related lactic acidosis: is it a myth or an underestimated reality? 172
[From hyponatremia to tolvaptan] 161
Both IL-1β and TNF-α Regulate NGALExpression in Polymorphonuclear Granulocytes ofChronic Hemodialysis Patients 155
Apelin beyond kidney failure and hyponatremia: a useful biomarker for cancer disease progression evaluation 146
[From oxygen to erythropoietin, as a protagonist of the skin-brain-kidney axis]. 144
Emerging markers of cachexia predict survival in cancer patients. 143
Sclerostin levels in uremic patients: a link between bone and vascular disease 139
Dialysis and the Elderly: An Underestimated Problem. 138
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R). 138
Delayed graft function and chronic allograft nephropathy: Diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin 133
Sevalamer Hydrochloride, Sevelamer Carbonate and Lanthanum Carbonate: In Vitro and In Vivo Effects on Gastric Environment 128
Central precocious puberty: from physiopathological mechanisms to treatment. 127
"Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL. 125
High mobility group box 1 and tumor growth factor β: useful biomarkers in pediatric patients receiving peritoneal dialysis 123
A Biotechnological T-Shirt Monitors the Patient's Heart during Hemodialysis. 120
Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy? 120
The erythropoietin and regenerative medicine: a lesson from fish 119
A new therapy for kidney injury: regeneration. 119
Down with the erythropoietin. Long live the erythropoietin! 119
High-mobility group protein B1: a new biomarker of metabolic syndrome in obese children 118
Fibrosis, regeneration and cancer: what is the link? 115
The concept of the urine test and specific reaction of the urine in various diseases according to Enrico Cauchi - member of the medical council of Malta (1933) 115
Before and after preeclampsia: What biomarkers are there? 115
Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment. 114
Erythropoietin and the truths of science. 114
La Genotossicità nel Paziente Uremico: un modello di studio sorprendente. 113
Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: Serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment 113
Hydrocarbons and kidney damage: Potential use of neutrophil gelatinase-associated lipocalin and sister chromatide exchange 111
From chronic kidney disease to transplantation: the roles of obestatin. 111
Kidney disease and psoriasis: novel evidences beyond old concepts 111
Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study 110
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression 109
The Myth of Water and Salt: From Aquaretics to Tenapanor 109
Apelin, Plasmatic Osmolality and Hypotension in Dialyzed Patients. 108
Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance? 104
Salt-water imbalance and fluid overload in hemodialysis patients: a pivotal role of corin 104
From water to aquaretics: a legendary route. 104
Kidney-lung connections in acute and chronic diseases: current perspectives 104
Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease 103
Pseudotumor cerebri syndrome and renal diseases in the pediatric population 103
Renal complications in oncohematologic patients. 102
Squilibri idrico-salini e sovraccarico di liquidi nei pazienti dializzati, il ruolo centrale di Corin 101
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease 101
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 100
Malnutrition in the elderly patient on dialysis. 100
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein. 100
High-mobility group box 1 in allergic and non allergic upper airway inflammation 100
Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? 99
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 99
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. 98
Serum levels of Apelin-36 are decreased in older hospitalized patients with heart failure 98
Persistent left superior vena cava and partially left inferior vena cava: A case report of a dangerous central venous catheterization 98
Thalassaemia major and infectious risk: High Mobility Group Box-1 represents a novel diagnostic and prognostic biomarker 97
Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis 96
Proteinuric effect of transcranial magnetic stimulation in healthy subjects and diabetic patients with stage 3-4 CKD 96
Levels of neutrophil gelatinase-associated lipocalin in 2 patients with crush syndrome after a mudslide. 96
Non-Invasive Imaging for Evaluating Cardiovascular Involvement in Patients with Primary and Lupus Nephritis. 96
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and progression of chronic kidney disease. 95
New options for the management of polycystic kidney disease 91
Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients 90
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Endothelial Progenitor Cells (EPCs) Evaluation in Aortic Aneurysm Repair. 90
Serum levels of apelin-36 are decresed in elderly hospitalized patients with heart failure 90
Regenerative medicine: does Erythropoietin have a role? 90
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease 88
Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function 87
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. 87
Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure 87
Renal biopsy: Still a landmark for the nephrologist 87
QUANTITATIVE ULTRASOUND OF BONE AND HANDGRIP STRENGTH ARE RELATED TO FRACTURE RISK IN HEMODIALYSIS PATIENTS 87
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 86
Vitamin D intoxication in two brothers: be careful with dietary supplements. 85
LMNA gene mutation as a model of cardiometabolic dysfunction: From genetic analysis to treatment response. 84
Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients 83
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. 83
Transient diabetes insipidus in pregnancy, diagnostic role of apelin and copeptin: A case report 81
Apelin and copeptin: two opposite biomarkers associated with kidney function decline and cyst growth in autosomal dominant polycystic kidney disease 78
Obestatin: a new element for mineral metabolism and inflammation in patients on hemodialysis. 77
Does Erythropoietin Always Win? 77
Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study 77
Erythropoiesis and chronic kidney disease–related anemia: From physiology to new therapeutic advancements 77
Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker? 74
NGAL is a precocious marker of therapeutic response. 73
Prolactin in obese children: a bridge between inflammation and metabolic-endocrine dysfunction 73
Acute Kidney Injury and Sepsis after Cardiac Surgery: The Roles of Tissue Inhibitor Metalloproteinase-2, Insulin-like Growth Factor Binding Protein-7, and Mid-Regional Pro-Adrenomedullin 72
Febrile Urinary Tract Infections in Children: The Role of High Mobility Group Box-1 71
Obestatin: an interesting but controversial gut hormone. 69
NGAL as an early biomarker of kidney disease in Joubert syndrome: three brothers compared. 69
New available biomarkers to face a worldwide emergency: The childhood obesity 68
[Tolvaptan and autosomal dominant polycystic kidney disease in the adult: let's give time to the "TEMPO" trial (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes)] 68
Increase in creatinine for the prediction of contrast-induced nephropathy 67
Left Ventricular Mass Index Predicts Renal Function Decline in Patients with Chronic Kidney Disease 65
Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients. 63
From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. 62
Regeneration and the Plant We have Inside 61
Neutrophil gelatinase-associated lipocalin in peritoneal dialysis reflects status of peritoneum. 61
Real-time monitoring of breath ammonia during haemodialysis: use of ion mobility spectrometry (IMS) and cavity ring-down spectroscopy (CRDS) techniques. 59
Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide 58
The future of phosphate binders: a perspective on novel therapeutics 57
Totale 10.095
Categoria #
all - tutte 40.991
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.991


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021246 0 0 0 0 0 51 21 13 23 69 42 27
2021/2022789 6 88 11 46 40 7 53 40 9 173 86 230
2022/20232.048 146 229 95 149 176 197 14 127 849 11 38 17
2023/2024626 33 70 22 53 49 259 7 22 8 37 7 59
2024/20252.414 42 26 49 142 85 103 87 461 568 196 265 390
2025/20262.857 444 503 622 539 656 93 0 0 0 0 0 0
Totale 10.528